We observed that co-expression genes with DAGLB or FBXO43 were significantly enriched in several classical cancer-related pathways, including MAPK, WNT, JAK-STAT, and P53 signaling (all FDR < 0.05; Supplementary Tables S7, S8). This evidence concerns the gene TP53 and cancer.